GSDME unlocks astrocyte-driven neurotoxicity in Alzheimer's Disease
Xie, X.; Ji, C.; Xu, J.; Lu, X.; Guo, G.; Liu, W.; Wu, X.; Chen, Y.; Zhang, Y.; Wang, J.; Li, J.; Hu, X.; Chen, S.; Wang, G.; Liu, Q.
Show abstract
Astrocytic calcium dysregulation and reactivity precede A{beta} deposition in amyloid-{beta} deposition in Alzheimers disease (AD) but the neurotoxic mechanisms remain unclear. We show that GSDME acts as a switch, linking MAM-mediated calcium release to astrocyte-driven neurotoxicity. Specifically, A{beta}-activated microglial signals activate astrocytic GSDME, releasing its N-terminal fragment, which targets MAMs and triggers ER calcium efflux. This induces biphasic CaMKII phosphorylation, initially boosting NRF2 defenses, then activating NF-{kappa}B-driven inflammation, shifting astrocytes from protective to toxic states. GSDME activation also drives astrocyte-derived exosomes (ADEs) to carry neurotoxic tau, proinflammatory miRNAs, and toxic lipids, propagating toxicity. GSDME deletion in AD mice reduces A{beta} burden, restores NF-{kappa}B/NRF2 balance, reprograms astrocytes and ADEs to protective states, and rescues cognition. Multi-omics profiling of serum ADEs from AD patients reveals a disease-specific signature with central neurotoxicity and peripheral immune regulation. These findings position GSDME as a promising dual diagnostic and therapeutic target for early AD invention.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Microglia Clear Neuron-released α-Synuclein via Selective Autophagy and Prevent Neurodegeneration 97%
- Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy 96%
- Novel brain-penetrant inhibitor of G9a methylase blocks Alzheimer’s disease proteopathology for precision medication 96%
Similar papers in this journal
- Sustained TREM2 stabilization accelerates microglia heterogeneity and Abeta pathology in a mouse model of Alzheimer s disease 96%
- Triglyceride metabolism controls inflammation and APOE4-associated disease states in microglia 96%
- Natural genetic variation determines microglia heterogeneity in wild-derived mouse models of Alzheimer's disease 96%
Similar papers in this journal
- Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration 96%
- Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model 96%
- The Alzheimers Disease Risk Genes MS4A4A And MS4A6A Cooperate to Negatively Regulate Trem2 and Microglia states 96%
Similar papers in this journal
Similar papers in this journal
- DAP12 deficiency alters microglia-oligodendrocyte communication and enhances resilience against tau toxicity 97%
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 96%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.